Members News

22.09.2020b.value invests in BELANO Medical AG
The b.value AG concluded its investment in BELANO medical AG at the end of August. The investment, together with the co-investor Deutsche Biotech Innovativ AG, should boost the commercialization of novel microbiome-based products. “We feel that BELANO’s microbiome paradigm offers great potential for innovative skincare and health products with a natural mechanism of action already proven in a wide range of studies.” pointed Dr. Georg Lentzen, member of the managing board of the b.value AG. The b.value AG is being pleased to be able to invest in such a promising company despite the unprecented times in 2020. This investment will support BELANO’s rise to a leading provider of microbiotic products.